Dongfeng Chen
- Biochemistry top 0.5%
- Phytochemicals and Antioxidant Activities 25
- Developmental Neuroscience top 1%
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 25
- MicroRNA in disease regulation 22
- Molecular Biology top 2%
- RNA modifications and cancer 13
-
- Free Radicals and Antioxidants 26
-
- Mesenchymal stem cell research 16
-
- Ferroptosis and cancer prognosis 15
-
- Nerve injury and regeneration 12
Dongfeng Chen
248 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Biochemistry 738
- Developmental Neuroscience 347
- Cancer Research 928
- Complementary and alternative medicine 471
- Molecular Biology 3.3k
Countries citing papers authored by Dongfeng Chen
This map shows the geographic impact of Dongfeng Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongfeng Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongfeng Chen more than expected).
Fields of papers citing papers by Dongfeng Chen
This network shows the impact of papers produced by Dongfeng Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongfeng Chen. The network helps show where Dongfeng Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongfeng Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 15 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 13 | |
| 10 | 2022 | 3 | |
| 11 | 2021 | 4 | |
| 12 | 2019 | 27 | |
| 13 | 2016 | 43 | |
| 14 | 2013 | 2 | |
| 15 | Antioxidant Activity of Rhizoma Cibotii in vitro | 2012 | 1 |
| 16 | Effects of Active Components of Rhizoma Acori Tatarinowii and Their Compatibility at Different Ratios on Learning and Memory Abilities in Dementia Mice | 2012 | 4 |
| 17 | Research on magnesium alloy surface alloying/ceramic composite layer by evaporative pattern casting technology | 2011 | 1 |
| 18 | Promoting effects of seropharmacological plastrum testudinis on the expression of bone morphogenetic protein 4 of rat mesenchymal stem cell in vitro | 2007 | 1 |
| 19 | Early diagnosis and prognosis in cerebral fat embolism syndrome | 2004 | 1 |
| 20 | Effect of Plastrum Testudinis on Neural Stem Cell After Focal Cerebral Ischemia | 2001 | 1 |
About Dongfeng Chen
Dongfeng Chen is a scholar working on Biochemistry, Cancer Research, Complementary and alternative medicine, Genetics and Developmental Neuroscience, having authored 266 papers that have together received 7.1k indexed citations. Recurring topics across this work include Free Radicals and Antioxidants (26 papers), Phytochemicals and Antioxidant Activities (25 papers), Cancer-related molecular mechanisms research (25 papers), MicroRNA in disease regulation (22 papers), Mesenchymal stem cell research (16 papers), Ferroptosis and cancer prognosis (15 papers), RNA modifications and cancer (13 papers) and Nerve injury and regeneration (12 papers). The work is most often cited by research in Biochemistry (738 citations), Developmental Neuroscience (347 citations), Cancer Research (928 citations), Complementary and alternative medicine (471 citations) and Molecular Biology (3.3k citations). Dongfeng Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xican Li, Susumu Tonegawa, Jie Shen, Weiming Xia, Roderick T. Bronson, Dennis J. Selkoe, Jean‐Claude Martinou, Gerald Schneider, Xiaozhen Wang and Hong Xie. Their work appears in journals such as Molecules, International Journal of Molecular Medicine, Human Immunology, International Immunopharmacology and BMC Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.